IF YOU SPEND any time in the fitness world—whether you’re scrolling through forums, listening to podcasts, or just talking to the biggest guy at the gym—you’ve probably heard the term “SARMs” thrown around. And just as often, you’ve likely heard them lumped together with anabolic steroids.
But here’s the thing: SARMs are not steroids. Not chemically, not legally, and most importantly, not in how they work inside the body.
Understanding the difference isn’t just a matter of semantics. It gets to the very heart of how these compounds were designed, why researchers are so interested in them, and what makes them fundamentally distinct from traditional performance-enhancing drugs.
So let’s break it down. No jargon for the sake of jargon. Just a clear, science-based look at what SARMs actually are, how they interact with your body, and why they’re in a category of their own.
To understand SARMs, you first have to understand the problem with steroids.
Anabolic-androgenic steroids (AAS) are synthetic derivatives of testosterone. When you take them, they bind to androgen receptors throughout your entire body. Think of it like flipping a hundred light switches at once.
In your muscles, that’s great—you get increased protein synthesis, faster recovery, and significant growth. But those same receptors exist in your prostate, your skin, your scalp, and your cardiovascular system. Flipping those switches triggers side effects: prostate enlargement, acne, hair loss, and negative impacts on cholesterol.
Steroids don’t discriminate. They activate androgen receptors everywhere. For decades, scientists accepted this as an unavoidable trade-off. If you wanted the muscle-building benefits, you had to accept the collateral damage.
SARMs — Selective Androgen Receptor Modulators — were developed to solve exactly this problem. The key word is selective.
Unlike steroids, which act like a sledgehammer on androgen receptors, SARMs were designed to act like a scalpel. They’re engineered to bind preferentially to androgen receptors in muscle and bone tissue while largely leaving receptors in other areas—like the prostate and skin—alone.
How? It comes down to molecular structure.
Steroids are steroidal molecules. They fit into the androgen receptor in a way that triggers a full, generalized response. SARMs, by contrast, are non-steroidal. Their unique three-dimensional shape causes the receptor to fold differently. This different folding pattern determines which co-regulatory proteins get recruited.
In muscle tissue, the receptor folds in a way that activates anabolic pathways. In prostate tissue, the same molecule induces a different conformation—one that either does nothing or actually blocks androgenic activity.
This is called tissue selectivity, and it’s the single most important distinction between SARMs and steroids.
If you want to get a little deeper into the mechanism, here’s how it works at the cellular level.
Androgen receptors are part of a family called nuclear receptors. When a molecule binds to them, the receptor changes shape and moves into the cell nucleus. There, it attaches to specific sections of DNA and recruits other proteins called coactivators or corepressors. These cofactors determine which genes get turned on or off.
Think of it this way: the androgen receptor is like a general-purpose computer. The ligand (the drug) is the software you install. Steroids are like running a program that uses 100% of the CPU—everything runs at max capacity. SARMs are like running a highly optimized program that only uses the resources it needs, leaving the rest idle.
Different tissues express different sets of coactivators. Muscle tissue, for example, has high levels of certain coactivators that SARMs are particularly good at recruiting. Prostate tissue has a different cofactor profile, which means the same SARM triggers a much weaker—or even opposite—response.
This is why compounds like Ostarine (MK-2866) and Ligandrol (LGD-4033) can produce significant strength and lean mass gains while maintaining a much cleaner side effect profile compared to traditional anabolics.
Let’s put it in practical terms.
| Feature | Anabolic Steroids | SARMs |
| Chemical Structure | Steroidal | Non-steroidal |
| Targeting | Systemic—activates receptors everywhere | Selective—prioritizes muscle and bone |
| Estrogen Conversion | Many steroids aromatize, causing water retention and gynecomastia | Generally do not convert to estrogen |
| Androgenic Side Effects | High risk (hair loss, acne, prostate issues) | Significantly reduced risk |
| Form | Injectable or oral | Primarily oral (tablets) |
| Legal Status in Canada | Controlled substances | Unapproved drugs (legal for research only) |
SARMs carry their own risks, including testosterone suppression, liver strain, and negative impacts on cholesterol. But the pattern of those risks is different. With steroids, you’re fighting systemic androgenic effects. With SARMs, the primary concerns are hormonal suppression and liver health—both of which can be managed with proper protocols like bloodwork, cycling, and post-cycle therapy.
It’s worth noting that not all compounds commonly grouped with SARMs actually work through the androgen receptor.
Take Cardarine (GW-501516), for example. Cardarine is not a SARM—it’s a PPARδ agonist. Instead of binding to androgen receptors, it activates a completely different pathway involved in fat metabolism and endurance. Researchers often pair it with SARMs because its mechanism is complementary: SARMs preserve muscle during caloric restriction, while Cardarine helps shift the body toward fat utilization.
This is why you’ll see products like ACP-105 alongside traditional SARMs in a quality catalog. Different compounds, different mechanisms, but all designed with a common goal: targeted, selective effects on specific biological pathways.
One practical difference that matters to researchers and athletes alike is how these compounds are delivered.
Traditional oral steroids are notoriously hard on the liver because they’re chemically modified to survive first-pass metabolism. SARMs, by contrast, were designed from the ground up for oral bioavailability. Modern SARMs in tablet form offer precision dosing that liquids simply can’t match.
Here’s the thing about liquid SARMs: you’re relying on a dropper. A slight tremor, a misread line, or a bottle that hasn’t been shaken properly can mean the difference between 10mg and 15mg. For compounds that affect hormone levels, that margin of error matters.
Tablet formulations—like those offered by NEO SARMs—eliminate that variable. Each tablet is pre-measured. You know exactly what you’re taking, every single time. No guessing. No taste issues. No bottles separating in the fridge.
In Canada, the landscape for SARMs is unique. This is where sourcing becomes critical. The market is flooded with products from overseas vendors that make bold claims but offer no proof of purity or consistency. For anyone serious about research—whether you’re a scientist, a biohacker, or an athlete who wants to understand what you’re putting in your body—domestic sourcing is the only sensible option.
NEO SARMs has built its reputation on exactly that: a 100% Canadian operation that guarantees 99% purity on all its products. From Ostarine for cutting research to Ligandrol for lean mass studies, from Cardarine for endurance to ACP-105 for dry gains, their catalog covers the full spectrum of research needs. They manufacture exclusively in tablet form, ensuring dosing accuracy. They offer free shipping across Canada on orders over $200. And they support researchers with educational resources and responsive customer service.
Here’s the bottom line.
Steroids and SARMs are not the same thing. They work through different mechanisms, carry different risk profiles, and serve different purposes in the research world. Steroids are systemic activators. SARMs are selective modulators.
If you’re looking to understand how androgen signaling works, how to preserve muscle during caloric restriction, or how to study the effects of tissue-selective receptor activation, SARMs like Ostarine, Ligandrol, and ACP-105 offer tools that steroids simply don’t.
But with that specificity comes responsibility. SARMs require respect. They require bloodwork. They require proper cycling and post-cycle therapy. And they require sourcing from vendors who prioritize quality over profit.
Whether you’re a researcher, an athlete, or just someone trying to make sense of the noise, knowing the difference between SARMs and steroids isn’t just academic. It’s the foundation for making informed, intelligent decisions.
This article was developed in collaboration with NEO SARMs, a trusted Canadian source for high-purity, tablet-form SARMs designed for research purposes. To explore their full catalog or learn more about responsible research protocols, visit neosarms.com.
If your bosses won’t listen on Slack, you can always try to make them do so in a courtroom
London Inc. Weekly: A summary of regional business news from the past week Photo: Loblaw Companies is set to open…
A growing share of employees are absorbing extra work without promotions, pay raises or formal title changes. Welcome to The…
Consumers are increasingly moving away from scheduled, time-bound leisure and toward what can be described as “anytime play”